Indiana NP Banned from Prescribing Pills After State Revocation
Published Date: 9/11/2026
Notice
Summary
Cheryl White, a nurse practitioner from Indiana, lost her DEA registration to handle controlled substances because she no longer has the legal authority to prescribe them in her state. She didn’t ask for a hearing to challenge this, so the DEA officially revoked her registration as of May 31, 2026. This means she can’t legally prescribe or manage controlled drugs anymore, affecting her medical practice and patients.
Analyzed Economic Effects
2 provisions identified: 0 benefits, 2 costs, 0 mixed.
DEA Registration Revoked
Cheryl White, N.P.'s DEA Certificate of Registration No. MW0411049 is revoked effective October 13, 2026. This revocation removes her federal authority to prescribe, administer, dispense, or otherwise handle controlled substances.
Pending Application Denials
Any pending applications by Cheryl White, N.P. to renew or modify her DEA registration, as well as any other pending applications for additional registration in Indiana, are denied effective October 13, 2026. The Order also directs that pending renewal or modification requests are not approved.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-11526, Implementation of the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act of 2018: Dispensing and Administering Controlled Substances for Medication-Assisted Treatment
Starting July 9, 2026, new rules make it easier for doctors and pharmacies to provide medicine that helps people recover from opioid addiction. These changes affect healthcare providers by expanding who can give medication-assisted treatment and how pharmacies can deliver these medicines. The goal? Faster, safer access to treatment with clear rules that save time and support recovery.
2026-10128, Revision of Applications for Manufacturing and Procurement Quotas
The DEA wants to update how companies apply for permission to make and buy certain controlled drugs and chemicals. These changes will make the rules clearer, help prevent drug shortages, and ensure enough supply for medical and scientific needs. If you’re a manufacturer or involved in this process, get ready to follow new steps and share your thoughts by July 20, 2026.
2025-05007, Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients
Starting December 31, 2025, veterans can get buprenorphine treatment and follow-up care through telemedicine, making it easier to access help for opioid use disorder without leaving home. This change affects veterans using VA health services and aims to improve treatment access while the government reviews feedback and policies. No new costs are mentioned, but the delay gives agencies time to ensure the rules work well.
2025-02793, Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients
The government is giving veterans easier access to buprenorphine treatment through telemedicine, letting them get care remotely. This change affects veterans using VA health services and aims to make treatment smoother and more convenient. The new rules were supposed to start February 18, 2025, but now they’ll kick in on March 21, 2025, while the government gathers public feedback.
2026-20749, Vladimir Romaniv, P.A.; Decision and Order
The DEA has officially suspended and is moving to revoke Vladimir Romaniv, P.A.'s registration because he gave multiple prescriptions without properly checking on a patient who was in jail. This affects Romaniv’s ability to prescribe controlled substances and signals serious legal trouble starting from late 2025. If you’re connected to his practice or rely on his prescriptions, expect changes and tighter controls soon.
2026-20750, L Krenk DBA Maui Clinic Pharmacy; Decision and Order
The DEA has officially revoked L Krenk DBA Maui Clinic Pharmacy’s registration because they broke important rules about where and how they handled controlled substances. This affects the pharmacy in Kahului, Hawaii, which can no longer legally dispense these drugs. The decision is final, and the pharmacy missed its chance to defend itself, so the revocation takes effect immediately, impacting their business and customers.
Previous / Next Documents
Previous: 2026-18598, Agency Information Collection Activities: Requests for Comments; Clearance of a Renewed Approval of Information Collection: Federal Aviation Regulation Part 119-Certification: Air Carriers and Commercial Operators
The FAA wants to keep collecting info from air carriers and commercial operators to make sure they follow safety rules. This renewal won’t change much but helps the FAA keep everyone flying safe and sound. If you’re involved in running or certifying airlines, you can share your thoughts by November 10, 2026—no extra costs or big changes expected!
Next: 2026-18603, Presidential Declaration Amendment of a Major Disaster for Public Assistance Only for the State of Mississippi
Good news for folks in Perry County, Mississippi! The government just updated its disaster help after Tropical Storm Arthur, adding Perry County to the list of places that can get public assistance. If you need a loan to fix storm damage, you’ve got until October 3, 2026, to apply for physical damage help and until May 3, 2027, for economic injury loans.